A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 11.10% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 60.28%. Over the past 30 days, the price of DXCM has leaped by -1.59%. And in the last five days, it has surged by 3.00%.
The market performance of Dexcom Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $142.00 on 03/26/24, while the lowest value for the same duration was $74.75 on 10/13/23.
52-week price history of DXCM Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Dexcom Inc’s current trading price is -2.91% away from its 52-week high, while its distance from the 52-week low is 84.44%. The stock’s price range during this time has been between $74.75 and $142.00. The trading volume for the Healthcare sector company’s shares reached about 3.24 million for the day, which was higher than the average daily volume of 3.04 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Dexcom Inc (DXCM) has experienced a quarterly rise of 8.20% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 53.15B and boasts a workforce of 9600 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 126.53, with a change in price of +21.69. Similarly, Dexcom Inc recorded 2,934,296 in trading volume during the last 100 days, posting a change of +18.67%.
DXCM’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DXCM stands at 1.25. Similarly, the long-term debt-to-equity ratio is also 1.24.
DXCM Stock Stochastic Average
Today, Dexcom Inc’s raw stochastic average for the past 50 days stands at 85.73%, indicating a rise from the raw stochastic average of the last 20 days, which was 67.86%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 41.28% and 27.75% respectively.
